2024

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy: the Spanish registry

   Blood

2. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

   International Journal of Medical Microbiology, Vol. 314

3. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

   Enfermedades Infecciosas y Microbiologia Clinica

4. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

   Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623

5. Are lead, cadmium and mercury risk factors for resistant hypertension?

   Journal of Trace Elements in Medicine and Biology, Vol. 84

6. Association between Asthma and Lower Levels of Physical Activity: Results of a Population-Based Case–Control Study in Spain

   Journal of Clinical Medicine, Vol. 13, Núm. 2

7. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

   The Lancet Oncology, Vol. 25, Núm. 1, pp. 46-61

8. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

   The Lancet Oncology, Vol. 25, Núm. 1, pp. 29-45

9. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective

   International Journal of Molecular Sciences, Vol. 25, Núm. 6

10. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

    Infectious Diseases

11. COVID-19: On the threshold of the fifth year. The situation in Spain

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 17-28

12. Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

    Seminars in Arthritis and Rheumatism, Vol. 64

13. Cannon A wave validation as a diagnostic tool in paroxysmal supraventricular tachycardias

    PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 3, pp. 383-391

14. Cerebral venous thrombosis

    Revista Clinica Espanola

15. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803

16. Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)

    Clinical and Translational Oncology

17. Clinical report of Bosma arhinia microphthalmia syndrome with a new variant on SMCHD1 gene. A case report

    Endocrinologia, Diabetes y Nutricion, Vol. 71, Núm. 3, pp. 138-143

18. Clinical, microbiological, and molecular characterization of pediatric invasive infections by Streptococcus pyogenes in Spain in a context of global outbreak

    mSphere, Vol. 9, Núm. 3

19. Clonal spread of fluconazole-resistant C. parapsilosis in patients admitted to a referral hospital located in Burgos, Spain, during the COVID-19 pandemic

    Mycoses, Vol. 67, Núm. 1

20. Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis

    Kidney International, Vol. 105, Núm. 1, pp. 177-188